(Q77797502)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9889747%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

review article

1 reference

title

Collagen vascular diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9889747%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

J P Callen

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9889747%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 November 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9889747%20AND%20SRC:MED&resulttype=core&format=json

Medical Clinics of North America

8 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9889747%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9889747%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9889747%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

1217-37, v

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9889747%20AND%20SRC:MED&resulttype=core&format=json

Polymyositis and dermatomyositis (first of two parts)

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970414-4

Management of antimalarial-refractory cutaneous lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970414-4

Chronic cutaneous lupus erythematosus. Clinical, laboratory, therapeutic, and prognostic examination of 62 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970414-4

Collagen-vascular disease: An update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970414-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970414-4

Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970414-4

Subacute cutaneous lupus erythematosus arising in the setting of calcium channel blocker therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970414-4

Association between bovine collagen dermal implants and a dermatomyositis or a polymyositis-like syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970414-4

A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970414-4

7 January 2021

Localized scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970414-4

Distinctive cutaneous subsets in the spectrum of lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970414-4

Induction of interstitial collagenase (MMP-1) by UVA-1 phototherapy in morphea fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970414-4

Scalp involvement in dermatomyositis. Often overlooked or misdiagnosed

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970414-4

Low-dose methotrexate administered weekly is an effective corticosteroid-sparing agent for the treatment of the cutaneous manifestations of dermatomyositis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970414-4

A retrospective review of 61 patients with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970414-4

Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970414-4

Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970414-4

Chlorambucil. An effective corticosteroid-sparing agent for patients with recalcitrant dermatomyositis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970414-4

Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970414-4

High-dose UVA1 radiation therapy for localized scleroderma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970414-4

Cutaneous changes of dermatomyositis in patients with normal muscle enzymes: dermatomyositis sine myositis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970414-4

The 1982 revised criteria for the classification of systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970414-4

Serum CA-125 screening for ovarian cancer in patients with dermatomyositis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970414-4

Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970414-4

10.1016/S0025-7125(05)70414-4

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9889747%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference